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Summary The human EB1 gene product was recently found. by a yeast two-hybrid screening. to be associated with the carboxy terminus of
the APC (adenomatous polyposis coli) protein, the product of a tumour-suppressor gene thought to act as a gatekeeper in colorectal
carcinogenesis. Because virtually all of the APC mutations result in the synthesis of carboxy-terminal truncated proteins, mutant APC proteins
are expected to lose their ability to interact with EB1 gene product. Thus, the interaction between APC and EB1 proteins may be important for
the tumour-suppressor activity of APC protein, and raises the hypothesis that EB1 is also involved in sporadic colorectal tumonrgenesis. To
investigate this hypothesis, somatic mutations in the entire coding sequence of EB1 cDNA were searched by reverse transcriptase single-
strand conformational polymorphism (SSCP) analysis in 21 sporadic colorectal cancers and seven adenomas. None of these tumours
contained somatic mutation, whereas a silent cDNA variant was identified in 14% of alleles. Furthermore, to investigate whether EB1 locus
was included within a region subjected to losses of heterozygosity, four polymorphism markers surrounding EB1 locus were surveyed. Onty
one out of 28 colorectal tumours contained a loss of heterozygosity at the D20S107 marker. In conclusion. the present findings strongly
suggest that EB1 gene is not invotved in somatic colorectal carcinogenesis.
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The adenomatous polposis coli gene (APC) on chromosome
5q2.1 encodes a tumour suppressor w-hich is assumed to act as a
gatekeeper in colorectal carcinogenesis (Kinzler et al. 1996). The
APC gene is mutated in about 75%c of colon cancer cell lines
(Smith et al. 1993) and 60%c of sporadic colorectal cancers
(Mlisoshi et al. 1992: Posell et al. 1992: Mis-aki et al. 1994). In
these tumours. APC mutations are thouaht to be an earlv event as
thev have been found in small benign adenomas (Powell et al.
1992). as well as in putative precursor ofcolorectal adenomas. i.e.
aberrant crypt foci (Smith et al. 1994a). In addition. inherited
mutations of APC gene are responsible for familial adenomatous
poly-posis. an autosomal dominant disorder that predisposes to
earlN deselopment of colorectal cancer (Groden et al. 1991:
Kinzler et al. 1991). Both germline and somatic mutations are
almost exclusivelv nonsense or frameshift mutations encoding for
truncated APC proteins lacking their carboxy-terminal half
(Nagase et al. 1993: De Vries et al. 1996).
The APC gene encodes a cvtoplasmic 2843-amino-acid protein
which is beliesed to act as a tumour suppressor. blocking the cell
cycle progression in G (Baeg, et al. 1995) and precipitating entry
into apoptosis of the colorectal epithelial cells (Monn et al. 1996).
In addition to these functional features. sesveral biochemical inter-
actions betseen APC gene product and other proteins haxse been
demonstrated. As a matter offact. the APC protein can form stable
homodimer swith its amino-terminal domains (Josly-n et al. 1993:
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Su et al. 1993). and can associate wsith seseral other proteins.
includinc P-catenin (Rubinfeld et al. 1993: Su et al. 1993). plak-o-
alobin (y-catenin) (Shibata et al. 1994). tubulin (Munemitsu et al.
1994: Smith et al. 1994b). gl-cogen svnthase kinase-31 (a
mammalian homologue of ZW-3 kinase) (Rubinfeld et al. 19961.
hDLG (a homologue of the Drosophila disc large tumour-
suppressor gene) (Matsumine et al. 1996) and a human protein
named EBI (Su et al. 1995).
EBI gene on chromosome 20q11.2 encodes for a nos el 268-
amino-acid protein which has been found to associate w-ith the
carboxyv-terminus of APC protein (codons 2167-2843) through a
yeast tu-o-hvbrid screening (Su et al. 1995). Recent immunopre-
cipitation assay have showsn that EB1 product can also associate
with -catemnn (Monn et al. 1996). Ahich has been found to partic-
ipate in the Wg/Wnt cell proliferation pathwsay. EB1 protein shares
little sequence similarity to other proteins except a calcium
channel from carp. the bactenral RNA pol merase 6-chain. the
Saccharomvces cerevisiae gene product YerO16p (Su et al. 1995)
and the closely related gene RPI (Renner et al. 1997). Although its
function remains unknown. the recent characterization of a puta-
tise EBI homologue in urochordate marine insertebrates suggests
that EB I protein has an important conservatisve cellular function
(Pancer et al. 1996). Because virtuallv all of the APC mutations
result in carboxv-terminal truncated products. APC mutant
proteins are expected to lose their abilits to interact with EBI oene
product. Thus. the interaction bets-een APC and EBI gene prod-
ucts may be important for the tumour-suppressor activity of APC
protein. and raises the hypothesis that EBI max also be insolved
in sporadic colorectal tumorigenesis. In order to insvesticate this
hypothesis. A-e analy sed 21 sporadic colorectal cancers and sesen
adenomas for EBI point mutations and losses ofheterozvgositV.
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MATERIALS AND METHODS
Tumour specimens
Twenty-one sporadic colorectal adenocarcinomas. seven
adenomas. and normal corresponding tissue specimens were
obtained from 21 patients (11 males and ten females) with mean
age 67.5 years (ranae 53-84 years) at the time of surgery at the
Institut Gustaxe Roussy. Accordinga to Astler-Coller's staging.
adenocarcinomas were classified as A in one case. B1 in tuo cases.
B2 in five cases. C1 in one case. C2 in four cases and D in eiaht
cases. Nine adenocarcinomas were located in the right colon. eight
were located in the left colon and four were located in the rectum.
Sesen tubular colorectal adenomas containing, severe dysplasia in
fise cases and moderate dysplasia in two other cases wvere also
anals sed. Five adenomas were located in the right colon. and txo
were located in the left colon. The sporadic nature ofthese tumours
was supported by the following criteria: (1) absence of tumour
microsatellite instabilitv searched Awith three A-mononucleotide
repeat loci (BATRII. BAT26 and BAT40) essentially as described
elsewhere (Markowitz et al. 1995: Liu et al. 1996): (2) presence
of fewer than fi e colorectal adenomas: (3) and absence of
Amsterdam's criteria in the patient's pedigree (Vasen et al. 1991).
All the tissues were snap frozen and stored in liquid nitrogen
until analysis. Tumour tissues x-ere dissected directly from the
surrounding normal areas by light microscopically directed
scraping of the specimens.
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Figure 1 Schematic locabon of pnmers pairs used for RT-SSCP analysis of
the EB1 cDNA coding sequence. The open box represents the coding region
of EB1 cDNA, whereas the 5' and 3' untranslated regions are shown as
shaded boxes. The location of the different pnmers are indicated in brackets.
The amplificabon was successively performed by amplifying the entire coding
sequence using the pnmers S1 and AS3, then re-amplifying the PCR product
into three overapping segments using the primer pairs Sl-AS1, S2-AS2 or
S3-AS3
Reverse transcription-polymerase chain reaction
(RT-PCR)
Total RNAs were isolated and purified usinr the modified guani-
dium phosphate buffer method (Chomczvnski et al. 1987) from
tumour-dissected specimens. Two micrograms of total RNA was
reverse transcribed using 200 ng of random hexamers. 20 units of
ribonuclease inhibitor. 200gnxI of deoxvnucleoside triphosphate
and 20 units ofavian myeloblastosis Xvirus enzvme (Perkins-Cetus.
Foster City. CA. USA) accordingr to manufacturer's instructions.
C G A C/T G A G G
Figure 2 SSCP autoradiograph (A) and sense strand sequence (B) of the S3-AS3 fragment in normal (N) and tumour specimens (T). Specimens 1 and 3 are
homozygous for 191 4 polymorphism. whereas 2 is heterozygous
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Figure 3 Allelico kss at the D20S107 kcus (arrow) in the genomic DNA of a
colorectal caracnmna (T) as compared with normal corresponding genomic
DNA (N)
The following primers pairs were designed to amplify the
entire EBI coding sequence in three overlapping segments (Figure
1): SI (sense). 5'-CGAGACGAAGACGGAACC-3'. and ASI
(antisense). 5'-AT-l-lGTCAACACCCATTCTCT-3': S2 (sense).
5'-CACGAGTACATCCAGAACT-T-3'. and AS2 (antisense).
5'-AGGGTTCTTTCGCACCACAC-3': S3 (sense). 5'-CCAGAG-
GCCCATCTCAAC-3'. and AS3 (antisense). 5'-CCGATGT-
TGCTCTGCTGGT-3'. To improve the specificity of the
polymerase chain reaction (PCR). the reaction was successively
performed by amplifying the entire coding sequence using the SI
and AS3 primers. then reamplifying the PCR products with the
primer pairs Sl-ASl. S2-AS2 or S3-AS3. The first PCR was
performed in 20-gil reaction mixtures containing, 1 gl of cDNA
mix. 150 nsi of SI and AS3 primers. 0.2 units of Taq polymerase
(Perkins-Cetus). 200 sm each of deoxyribonucleoside triphos-
phate. 2 m-m ofMgCl,. in Taq buffer. After an initial denaturation
step of 94°C for 5 min. the PCR was carried out for 35 cycles of
94°C for 30 s. 54°C for 30 s and 72°C for 1 min. and terminated
by a final extension at 72°C for 10 min. One microlitre of the
1:1000 diluted PCR products was reamplified as previously in
20-il reaction mixtures containing 150 mm of each primer
pairs aforementioned. 0.1Igl of [a- RP]dATP (5000 Ci mmol-'.
Amersham. UK). 5% of dimethylsulphoxide. 0.2 units of Taq
polymerase. 5 gms each of deoxyribonucleoside triphosphate and
2.5 ntm magnesium chloride.
Single-strand conformational polymorphism (SSCP)
analysis
Conformnational changes in PCR products were analysed by SSCP
analysis as previously described (Lazar et al. 1994). Briefly. 5gil of
radiolabelled PCR products was diluted with 20 jl of0.1% SDS. 10
m-¶ EDTA pH 8.0 mixed 1:1 with formamide dye (deionized
formamide. 0.05% bromophenol blue and 0.05% xylene cyanol).
heat denatured at 950C for 2 min. and chilled on ice before loading.
Five microlitres of the mixture was loaded to Hydrolink MDE gels
(FMC. Rockland. ME. USA) with 8% glycerol forroomtemperature
gels orwithout glycerol for4°C gels. Electrophoresis was carried out
for 14 and 18 h at 8 W constant powerfor4°C and room temperature
gels respectively. Gels were transferred to Whatman 3MM paper.
dried on a vacuum-slabdryerandautoradiographed for 12-24 h with
an intensifying screen. Base pairchanges were identified by shifts in
the pattem ofsingle-stranded DNA conformers.
Sequence analysis
PCR products displaying abnormal pattern were purified using
Microspin columns (Pharmacia. Uppsala. Sweden). and directly
sequenced with the deoxytermination method using fluorescently
tagged dideoxyribonucleoside (Applied Biosystems. Foster City.
CA. USA) on the Applied Biosystems model 373A DNA
sequencer. The sequences were compared with the published
human EB1 cDNA sequence (Genbank accession number
U24166) using the Sequence Navigator package (Applied
Biosystems).
Analysis of allelic loss
To determine whether EBI was included within a region under-
going losses of heterozygosity in colorectal cancers. DNA
from dissected frozen tumour specimens and normal corres-
ponding tissues were extracted using standard methods (Maniatis
et al. 1989) and subjected to PCR amplification of the poly-
morphic microsatellite markers surrounding EBI at loci
D20S112 (AFM197xbl12 ). D20S195 (AFM321xcl). D20S107
(AFMI42xh4) and D20S178 (AFM240vd6) (Chumahov et al.
1995). After amplification for 40 cycles with annealing tempera-
ture at 50°C and incorporation of [ax- P]dATP. PCR products were
separated on 6% denaturing polyacrylamide gels (acrylamide. N-
N'-bisacrylamide: 28:2). and autoradiography was performed.
Allelic loss was scored if the autoradiographic signal was at least
50% reduced when compared with the corresponding normal allele.
RESULTS AND DISCUSSION
To improve the specificity ofthe reaction. EBI cDNA was ampli-
fied in two steps. In the first step. the entire coding, sequence
was amplified using the primers SI and AS3 in 28 sporadic colo-
rectal tumour specimens and normal corresponding tissues.
Amplification gave a unique product of897 bp. indicating the lack
of abnormal splicing of EB1 mRNA. In the second step. SSCP
analysis of both tumour and normal specimens was performed by
reamplifying the previous PCR products with the primer pairs
S1-ASI, S12-AS2 or S3-AS3. No change in the electrophoretic
mobility was found in colorectal cancer specimens only. indicating
the lack of somatic mutation. Seven tumours and normal corre-
sponding specimens contained sequence alterations ofthe S3-AS3
fragment as shifts in the electrophoretic mobility of single-
stranded conformers (Figure 2A). Sequence analysis found a silent
polymorphism changing a C to T in the third base of codon 191
(191- F to 191-P) (Figure 2B). No additional difference with the
published sequence was found when sequencing the entire coding
sequence ofEBJ.
To determine whether EBI locus. which maps on chromosome
2Oq11.2 (Su et al. 1995). was subjected to losses ofheterozygosity.
four polymorphic microsatellite markers surrounding the EBI
locus were amplified in both tumour and normal DNAs. The
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normal tissues were heterozygoous for all four markers in the 28
analysed tumours. Allelic loss at the locus D2'O 107 on the
20q1 1.2 region w-as found in only 1 out of the 28 tumours (Figure
3). This finding is consistent with previous allelotype analysis of
colorectal cancers showing the low frequency of20q chromosome
losses (Vogelstein et al. 1989: Thorstensen et al. 1996).
Incidentally. microsatellite instability was found in two cancers
wvith only one dinucleotide marker.
In the present study. we have tested the hypothesis that EBI
alterations may occur alternatively to APC mutations in human
sporadic colorectal cancers. Although APC mutations were not
searched for in the 28 tumours of this study. we probably analysed
several tumours containing wild-type APC gene. since no APC
mutations are found in about 40%7c of colorectal cancers (Mivoshi
et al. 1992: Powell et al. 1992: Mivaki al. 1994). Reaardless ofthe
APC gene status. the results described above provide evidence that
EBI is not subjected to point mutations and is not included within
a region undergoing losses of heterozvgosity in a significant
number ofhuman sporadic colorectal cancers. However. it remains
possible that more subtle alterations. such as mutations in the
promoter region or abnormal DNA methylation. could inactivate
EBI alleles in human colorectal cancers. As a matter of fact.
chances in the methvlation status have been show-n to affect
various genes involved in sporadic colorectal carcinogenesis. such
as APC (Hiltunen et al. 1997). and hMLHI (Kane et al. 1997).
In conclusion. the present data suggests that EBI is not involved
in the development of human sporadic colorectal cancers.
Note added in proof
Since the submission of this article. EB 1 product has been shown
to localize to microtubules in i-vo. in both fission (Beinhauer et al.
1997) and buddinga yeast (Schwartz et al. 1997). In addition. the
function of EB 1 product has been recently clarified in yeast
(Muhua et al. 1998). In those cells. mutation of EBI homologrue
has been shown to abolish the cell-cycle delay induced by
misalignment of the mitotic spindle. These findings suggest that
EB 1 may be necessary to maintain neutral ploidy througrh this cell-
cycle checkpoint mechanism.
ABBREVIATIONS
APC. adenomatous polyposis coli: PCR. polymerase chain reac-
tion: SSCP. single-strand conformational polymorphism: RT.
reverse transcriptase: SDS. sodium dodecvl sulphate.
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